In the media

<p>Image: CSIC</p>
20 Aug 2018 - LA VANGUARDIA & OTHER MEDIA

El Independiente, Catalunya Ràdio and La Vanguardia have interviewed Raúl Méndez, ICREA researcher at IRB Barcelona, to learn more about the recently published study on autism. Méndez points out that despite the importance of the discovery, "we are 'far away' from achieving a cure or solution to the autism spectrum disorder, although it will allow us to focus future studies in this direction."

Link to El Independiente

Link to...

<p>Source: Unsplash</p>
17 Aug 2018 - RTVE & Other Media

RTVE, Ara, 20 Minutos, Daily Mail, Jornal Médico, Sic Noticias, among other national and international media, have published articles about a recent study on autism. Researchers co-led by Raúl Méndez, head of the Translational Control of Cell Cycle and Differentiation Lab at IRB Barcelona, have discovered that the protein CPEB4, a molecule that regulates protein synthesis, is impaired in most cases of autism.

Link to RTVE

Link to...

<p>La República</p>
13 Aug 2018 - La República

Immunotherapy is gaining ground in the fight against cancer. The tumour has a strategy to evade detection by the immune system, thus allowing it to spread throughout the body. Science has discovered this therapy and is working on overcoming this evasion strategy. In this regard, La República has published an interview with Eduard Batlle, head of the Colorectal Cancer Lab at IRB Barcelona.

 

<p>Image: Sandra Segura, IRB Barcelona</p>
10 Aug 2018 - Catalunya Press & Other Media

Catalunya Press, Revista Genética, among other national and international media, have published articles about a study co-led by Travis H. Stracker, head of the Genomic Instability and Cancer Lab, which has identified a key role for enzymes in DNA replication and sensitivity to chemotherapeutic drugs.

Link to Catalunya Press

Link to Revista Genética

Link to...

<p>Image: IRB Barcelona</p>
1 Aug 2018 - Infosalus & other media

Infosalus, Medicina TV, Bolsamania, Bioengineer and Medi Magazine, among other national and international media, have published an article about the recent study led by the Structural Bioinformatics and Network Biology Lab. This research demonstrates that cancer cells proliferate less and in a less robust manner when their internal pH is lowered, that is to say it becomes more acidic.

Link to Infosalus

Link to...

<p>Image: Premsa del Baix</p>
31 Jul 2018 - Premsa del Baix

Premsa del Baix has published an article about the athletes of Sant Esteve de Sesrovires who have received awards at the "Sports Night". Carlos Romero, a long-distance swimmer, won the prize for best athlete in the men's category. Romero combines sports and fundraising to support the Institute for Biomedcine Research (IRB Barcelona).

Link to Premsa del Baix

<p>Miguel Rovira, researcher at IRB Barcelona</p>
30 Jul 2018 - TV3

TV3's "Telenotícies" programme interviewed Miguel Rovira, a PhD student at IRB Barcelona and the first author of a recent study published in the journal EMBO Molecular Medicine. In this study, the scientists designed a nano-carrier to release drugs into damaged cells.

Link to TV3

Link to TV3 (vídeo)

 

<p>Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory at IRB Barcelona.</p>
27 Jul 2018 - El Punt Avui & other media

El Punt Avui, Al Día, Noticias de la Ciencia, Catalunya Press, among other media, have published an article about a study led by Manuel Serrano, leader of the Laboratory of Cellular Plasticity and Disease at IRB Barcelona, which establishes therapeutic opportunities to eliminate senescent cells in diseases such as cancer.

Link to El Punt Avui

Link to Al Día

Link to...

<p>Roger Gomis, head of the Growth Control and Cancer Metastasis Lab</p>
26 Jul 2018 - Biotech Spain

The biotechnology portal Biotech Spain has published an article about the award of funding from “la Caixa” foundation to develop the project "Metastasis Cell Fate Mapping", headed by Roger Gomis, ICREA research at IRB Barcelona.

Link to Biotech Spain

<p>Salvador Aznar Benitah leads the Stem cells and cancer lab at IRB Barcelona</p>
25 Jul 2018 - Agencia SINC

The agency SINC has interviewed Salvador Aznar Benitah, head of the Stem Cell and Cancer Lab at IRB Barcelona, about his work at the centre, but mainly on the research he does on metastasis and its relationship with fatty acids: "In our research with stem cells, we found that some populations ate fat and had a huge apetite for palmitic acid (the main component of palm oil). When we prevented the cells from consuming fatty acids, we almost completely stopped the metastases, " said Aznar Benitah.

Link to SINC